Podcast: Regulus Therapeutics and Outsourcing Strategies - - BioPharm International

ADVERTISEMENT

Podcast: Regulus Therapeutics and Outsourcing Strategies


blog comments powered by Disqus


Focusing on outsourcing strategies, BioPharm International interviews for a second time Bal Bhat, senior director and head of chemistry at Regulus, a company that develops and manufactures oligonucleotides to support the discovery and development of microRNA therapeutics. Bhat discusses the reasoning behind Regulus’ choice of outsourcing partners and how working closely with those partners to harmonize methodology and data quality is crucial. Bhat also describes how engaging outsourcing partners with the excitement of microRNA technology enabled an improved working relationship with shared goals. Posted Nov. 2011.

Related article on Perspectives in MicroRNA Therapeutics

Podcast: Dr. Bhat focuses on microRNA Drug Delivery

ADVERTISEMENT

ADVERTISEMENT

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator
November 26, 2014
Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine
November 25, 2014
FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma
November 25, 2014
AstraZeneca Expands Biologics Manufacturing in Maryland
November 25, 2014
GSK Leads Big Pharma in Making Its Medicines Accessible
November 24, 2014
Author Guidelines

Click here